← Home
Speaking

A clear voice on advanced myeloma therapy.

Dr. Mewawalla speaks to oncologists, care teams, and patient communities about how to choose, sequence, and safely deliver CAR T-cell therapy and bispecific antibodies, including beyond major academic centers.

Signature Talks

Topics she's regularly invited to present.

Sequencing CAR T-cell Therapy and Bispecific Antibodies in Multiple Myeloma
Choosing what comes first, and next, at relapse.
Delivering Bispecific Antibodies Safely in Community Practice
Step-up dosing, monitoring, and readiness for community programs.
Bringing Advanced Myeloma Therapy Closer to Home
Extending specialized care beyond major academic centers.
Managing Toxicities Across BCMA- and GPRC5D-Directed Therapies
Practical toxicity recognition and management.
The Future of Myeloma: From Disease Control Toward Functional Cure
Where the science is heading and what it means for patients.
Recent Engagements

Where she's spoken lately.

Invited International Faculty · New Delhi & Gurugram, India
2026 · Lectures on sequencing from anti-CD38 to bispecifics and on BCMA- and GPRC5D-directed therapy at AIIMS, Rajiv Gandhi Cancer Institute, and HemeNext 2.0.
Opinions in Multiple Myeloma Regional Forum (Curio Science), Philadelphia
2026 · Invited speaker and panel moderator on management of late relapsed/refractory myeloma and bispecific antibodies.
Multidisciplinary Amyloid Symposium, University of Kansas Medical Center
2026 · "Initial Treatment of AL Amyloidosis: A Practical Approach for Clinicians."
Carnegie Mellon University · Invited Guest Lecturer
2026 · Guest speaker for a graduate course in health policy.
Best of ASCO®, Pittsburgh · Faculty
2026 · Practice-changing advances in multiple myeloma & AL amyloidosis (MajesTEC-9, CARES, SUCCESSOR-2, and more).
National Immune Effector Cell Therapy Congress, Charlotte
2026 · Bispecific antibodies in myeloma and the imperative of expanding access to the community.
Highlights of ASH® · Course Director
2025 · Directing a program on practice-changing advances in multiple myeloma from the ASH annual meeting.
International Cell Effector Therapy (ICE-T) Congress, Univ. of Kansas Medical Center
2025 · "Advances in CAR T-cell Therapy for Multiple Myeloma," plus expert panels on CAR T-cell therapy and bispecific antibodies.
Tri-State Hematology & Oncology Association
2025 · Updates on bispecific antibody therapy in multiple myeloma.
RAPS Convergence, Opening Session Panelist
2025 · "Rebuilding trust in science," opening a large global regulatory conference.
Course Director, AHN Physician Wellness Conference
2026 · Leading a conference on clinician wellness, sponsored by the AHN Women Physicians ERG.
Gallery

On stage.

Dr. Prerna Mewawalla presenting at Best of ASCO 2026, Pittsburgh
On Stage

Best of ASCO® 2026, Pittsburgh

Presenting the most important practice-changing advances in multiple myeloma. "What makes these meetings valuable is not just discussing new developments, it is examining how we translate that evidence into better treatment selection, thoughtful sequencing, and meaningful outcomes for our patients."

From the stage

Invited lectures, panels, and plenaries across national and international myeloma and cellular therapy meetings.

Dr. Mewawalla presenting Advances in CAR T-cell Therapy for Multiple Myeloma at the ICE-T Congress
"Advances in CAR T-cell Therapy for Multiple Myeloma", ICE-T Congress (Univ. of Kansas Medical Center).
Dr. Mewawalla presenting MAGNETISMM-3 (elranatamab) data at the National ICE-T Congress, Charlotte, NC
Presenting MAGNETISMM-3 (elranatamab) data — Bispecifics in Myeloma, National ICE-T Congress, Charlotte, NC (2026).
Dr. Mewawalla at the Best of ASCO podium
Best of ASCO® 2026, Pittsburgh, practice-changing advances in myeloma.
Dr. Mewawalla presenting at Highlights of ASH, Fairmont Pittsburgh
Highlights of ASH®, Fairmont Pittsburgh (2026).
Dr. Mewawalla presenting at a podium, Omni William Penn Hotel, Pittsburgh
Presenting at the Omni William Penn Hotel, Pittsburgh.
Dr. Mewawalla presenting on GPRC5D targeting at the HemeNext 2.0 podium, Gurugram, India
“Beyond BCMA: GPRC5D Targeting in RRMM,” HemeNext 2.0, Gurugram, India (2026).
Dr. Mewawalla as Course Director at the Physician Wellness Conference, Atterbury Hotel
Course Director, Physician Wellness Conference, Atterbury Hotel (2026).
Dr. Mewawalla on the opening plenary panel at RAPS Convergence 2025
Opening plenary panel, RAPS Convergence 2025.
Dr. Mewawalla as a faculty panelist at the AJMC Driving the Future of Cancer Care event
Faculty panelist, AJMC — Driving the Future of Cancer Care (2025).
Dr. Mewawalla on the main stage before a global audience at RAPS Convergence 2025
Opening plenary before a global audience, RAPS Convergence 2025.
Dr. Mewawalla speaking at HemeNext 2.0 shown on the main conference screens, Gurugram, India
Invited international faculty, HemeNext 2.0, Gurugram, India (2026).
The HemeNext 2.0 conference hall with myeloma slides on the screens, Gurugram, India
HemeNext 2.0: The Future of Blood, Gurugram, India (2026).
Dr. Mewawalla on an expert panel discussing a myeloma case scenario at HemeNext 2.0
Panel: Building the Modern Myeloma Treatment Pathway, HemeNext 2.0, Gurugram (2026).
Dr. Mewawalla speaking on the expert panel at HemeNext 2.0, Gurugram, India
On the expert panel, HemeNext 2.0, Gurugram, India (2026).
Dr. Mewawalla on the faculty panel at the Multidisciplinary Amyloid Symposium, University of Kansas
Faculty, Multidisciplinary Amyloid Symposium, University of Kansas Medical Center (2026).
Best of ASCO 2026 title slide, Practice-Changing Advances in Multiple Myeloma and AL Amyloidosis, presented by Prerna Mewawalla, MD
Invited faculty, Best of ASCO® 2026, Practice-Changing Advances in Multiple Myeloma and AL Amyloidosis.
Audiences & Formats

Who she speaks to, and how.

Audiences

Community & academic oncologists · advanced-practice providers & nursing · tumor boards & grand rounds · patient & caregiver groups · industry medical/scientific meetings.

Formats

Plenary & lectures · CME lectures · panel moderation & participation · case-based workshops · fireside chats · virtual webinars & podcasts.

Provided on request

High-resolution headshots · slide previews · learning objectives · disclosure statement · ready-to-use biographies.

For Organizers

Speaker kit.

Print-ready headshots and ready-to-use biographies for programs and introductions.

Speaking inquiries

Speaking & media inquiry.

This form opens your own email application with the details pre-filled and sends the message from your email account. The website does not store or transmit any information you enter. Please don't include protected health information.